The cases reported by Grohé et al are interesting, but they need to be better debated.1 As far as we know, we were the first group to administer anti-IgE to a patient with Churg–Strauss syndrome (CSS) with asthma.2 3

In our patient, CSS had shown remission with systemic corticosteroid but he still presented with asthma which was difficult to control. The asthma did …